Document Detail


Eosinophilia myalgia syndrome.
MedLine Citation:
PMID:  9213377     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The term eosinophilia myalgia syndrome (EMS) was coined in 1989 after a cluster of cases with symptoms of incapacitating myalgias and eosinophilia were reported. This syndrome has been only defined as varying degrees of myalgias and peripheral eosinophilia. Case reports of EMS are protean and do not show a consistent clinical picture, raising the question of whether this reflects a single disorder or is a conflation of various disorders. There have been only two studies evaluating the association of EMS with 1-tryptophan. These two included only 23 patients with EMS. Apart from the obvious statistical fragility inherent in such small studies, each is further weakened by differences in the mechanisms by which patients and controls were selected. Furthermore, the continued reports of EMS after 1-tryptophan was removed from the market raise additional questions about the association. Nonetheless, there has been an inordinate reliance on a history of 1-tryptophan ingestion in making the diagnosis of EMS. When presented case studies, clinicians were much more likely to make the diagnosis of EMS when a history of 1-tryptophan ingestion was included. These observations underscore the need for careful application of well-considered diagnostic criteria to the study of new syndromes and their potential associations.
Authors:
W D Blackburn
Related Documents :
15610957 - Neuroleptic malignant syndrome and clozapine withdrawal at the same time?
24614547 - Orbital osteoma: clinical features and management options.
24419237 - Quality of reporting of phase ii trials: a focus on highly ranked oncology journals.
392097 - Search for reiter's syndrome after an outbreak of shigella sonnei dysentery.
21892297 - Primary adrenal leiomyosarcoma: a case report and literature review.
2302887 - Ankle arthroplasty. a comparative study of cemented metal and uncemented ceramic prosth...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Seminars in arthritis and rheumatism     Volume:  26     ISSN:  0049-0172     ISO Abbreviation:  Semin. Arthritis Rheum.     Publication Date:  1997 Jun 
Date Detail:
Created Date:  1997-08-21     Completed Date:  1997-08-21     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  1306053     Medline TA:  Semin Arthritis Rheum     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  788-93     Citation Subset:  IM    
Affiliation:
Division of Clinical Immunology and Rheumatology, Birmingham VA Hospital (111-F), AL 35233, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Diagnosis, Differential
Eosinophilia-Myalgia Syndrome / chemically induced,  diagnosis*
Humans
Tryptophan / adverse effects
Chemical
Reg. No./Substance:
73-22-3/Tryptophan
Comments/Corrections
Comment In:
Semin Arthritis Rheum. 1997 Jun;26(6):781-4   [PMID:  9213375 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The changing prognosis of ARDS.
Next Document:  Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate t...